A multi-center phase II study of sequential paclitaxel and bryostatin-1 (NSC 339555) in patients with untreated, advanced gastric or gastroesophageal junction adenocarcinoma. (Q53346443)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A multi-center phase II study of sequential paclitaxel and bryostatin-1 (NSC 339555) in patients with untreated, advanced gastric or gastroesophageal junction adenocarcinoma. |
scientific article |
Statements
A multi-center phase II study of sequential paclitaxel and bryostatin-1 (NSC 339555) in patients with untreated, advanced gastric or gastroesophageal junction adenocarcinoma. (English)
1 reference
Jaffer A Ajani
1 reference
Yixing Jiang
1 reference
Josephine Faust
1 reference
Baochong B Chang
1 reference
Linus Ho
1 reference
James C Yao
1 reference
Steven Rousey
1 reference
Shaker Dakhil
1 reference
Richard C Cherny
1 reference
Catherine Craig
1 reference
Archie Bleyer
1 reference
1 July 2006
1 reference
24
1 reference
4
1 reference
353-357
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference